RYAN PETTY: Open Payments
NPI 1902331598 · LINDEN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 58 payments from 13 companies in 2025. Trend: 2023 $732 · 2024 $1,221 · 2025 $1,046
Food & beverage: $1,046
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $246 |
| ABBVIE INC. | 15 | $239 |
| PFIZER INC. | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Exact Sciences Corporation | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 2 | $31 |
Products named: NURTEC ODT, VRAYLAR, QULIPTA, Rybelsus, Ozempic, Kerendia, Cologuard Collection Kit, Wegovy.
Industry payments across MI — which companies pay providers there.
